U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
Indium In-111 pentetate disodium is a radioactive diagnostic indicated for use in radionuclide cisternography. Decay of In-111 by electron capture allows for detection with a gamma camera for visualization of the brain and spinal column. Indium In 111 pentetate ( 111In-DTPA) is indicated as an imaging agent in cisternography to study the flow of cerebrospinal fluid (CSF) in the brain, to diagnose abnormalities in CSF circulation, to assess and help localize the site of CSF leakage, and to test the patency of or localize blocks in CSF shunts.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
MPI INDIUM DTPA IN 111

Approved Use

Unknown

Launch Date

1982
Diagnostic
MPI INDIUM DTPA IN 111

Approved Use

Unknown

Launch Date

1982
Diagnostic
MPI INDIUM DTPA IN 111

Approved Use

Unknown

Launch Date

1982

Sample Use Guides

The maximum recommended intrathecal dose in the average patient (70 kg) is 18.5 MBq, 500 μCi. The patient dose should be measured by a suitable radioactivity calibration system immediately prior to administration.
Route of Administration: Other
Name Type Language
INDIUM IN-111 EPRATUZUMAB TETRAXETAN
Common Name English
EPRATUZUMAB TETRAXETAN INDIUM IN-111
Common Name English
INDIUM IN 111 LL2 IGG
Common Name English
111IN-DOTA EPRATUZUMAB
Common Name English
Code System Code Type Description
FDA UNII
4L3VFU7249
Created by admin on Sat Dec 16 16:07:44 GMT 2023 , Edited by admin on Sat Dec 16 16:07:44 GMT 2023
PRIMARY
NCI_THESAURUS
C2217
Created by admin on Sat Dec 16 16:07:44 GMT 2023 , Edited by admin on Sat Dec 16 16:07:44 GMT 2023
PRIMARY